SCHEMBL4255128

SCHEMBL4255128

CCc1ccc(C(=O)Nc2c(C(N)=O)oc3c(F)cc(F)cc23)o1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
PTGDR2 Q9Y5Y4 1/20 0.42
MAPK10 P53779 5/20 0.39
HSD17B10 Q99714 4/20 0.39
MAPT P10636 4/20 0.39
TSHR P16473 3/20 0.39
TP53 P04637 3/20 0.39
AHR P35869 1/20 0.39
KMT2A Q03164 4/20 0.39
MEN1 O00255 3/20 0.39
POLB P06746 2/20 0.38
RXFP1 Q9HBX9 1/20 0.38
ALDH1A1 P00352 3/20 0.37
PKM P14618 1/20 0.37
HPGD P15428 3/20 0.36
LMNA P02545 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
ALOX15 P16050 1/20 0.36
S1PR2 O95136 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13700052 0.89 MAPT (0.39) PTGDR2MAPK10HSD17B10MAPTTSHR
SCHEMBL13700233 0.89 MAPT (0.40) NPC1RAB9APTGDR2MAPK10HSD17B10
SCHEMBL13700228 0.89 SMYD3 (0.41) NPC1RAB9APTGDR2MAPK10HSD17B10
SCHEMBL13700044 0.88 ATM (0.43) NPC1RAB9AMAPK10HSD17B10MAPT
SCHEMBL4259581 0.86 MAPT (0.53) NPC1RAB9APTGDR2MAPK10HSD17B10
SCHEMBL13700241 0.85 PTGDR2 (0.36) NPC1RAB9APTGDR2MAPK10HSD17B10
SCHEMBL4253483 0.84 TP53 (0.42) PTGDR2MAPK10HSD17B10MAPTTSHR
SCHEMBL13700247 0.84 MAPT (0.39) NPC1RAB9APTGDR2MAPK10HSD17B10
SCHEMBL13700243 0.84 MAPT (0.40) NPC1RAB9APTGDR2MAPK10HSD17B10
SCHEMBL4252531 0.84 TP53 (0.50) NPC1RAB9APTGDR2MAPK10HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US claimed
EP-1710233-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE Kissei Pharmaceutical Co., Ltd. (JP) 2006-10-11 EP claimed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
EP-1710233-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE Kissei Pharmaceutical Co., Ltd. (JP) 2006-10-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE ADORA2A, ADORA2B, HTR1F NPC1 3348/4885RAB9A 1928/4885PTGDR2 421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.